EN DE

National HealthCare Corporation (NHC) Fair Value & Analysis

Healthcare · US · Market cap $3.3B

NH National HealthCare Corporation logo National HealthCare Corporation NHC · US
Price$215.54
Fair Value$157.66
Upside-26.9%
Quality72/100
Watch National HealthCare Corporation for free, get notified when fair value or trend changes. Watch for free
Healthy Growth
Thin margins · 8.1% net margin
Low debt · generates free cash flow
1.20% dividend yield
Mixed vs. peers (6/15)
Moderate moat 46/100
Evidence: High Range $113.81 – $196.69 Share as image

Fair value as of: Jul 14, 2026

From 26 valuation models · updated 27 days ago

Fair value updated Jul 14, 2026, revised from $168.98 to $157.66 (−6.7%) since Jun 24, 2026. Share price +1.8% over the past month.

A solid business, but screening 27% overvalued on our models.

What matters now

  • A high-quality business (quality 72/100), yet the market already pays well above fair value. Quality at a full price, with little margin of safety.
  • The price sits above even our optimistic bull case ($196.69). The favourable scenario is already priced in.
Share this valuation: 𝕏 WhatsApp

Price vs Fair Value (5 years)

$231.00 $48.06 Fair Value $157.66 May 2021 Aug 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 14, 2026.

How to read this chart

60‑month range $48.06 – $231.00 · fair‑value band $113.81 – $196.69 · the $215.54 price screens above the $157.66 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Jul 14, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

National HealthCare Corporation (NHC) currently trades at $215.54, while our model-based Fair Value estimate is $157.66, implying the stock looks roughly 26.9% overvalued today. The Quality Score stands at 72/100 (solid quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: high).

Over the trailing twelve months, National HealthCare Corporation generated revenue of $1.5B at a net margin of 8.1%. Revenue grew 2.2% year over year. It earns a return on equity of 12.0%. The balance sheet holds a net cash position of $23.9M. Fundamentals as of Jul 14, 2026

Our scenario range runs from $113.81 (bear case) to $196.69 (bull case); at $215.54, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades near its 52-week high and 134% above its 52-week low, currently above its 200-day average. For context, the median of 10 Healthcare peers we cover trades at 11% fair-value upside, at -27%, NHC screens richer than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Model BearBaseBull Evidence
Highest evidence
Growth DCF $106.31 $147.86 $203.42 80
Residual Income $61.18 $69.38 $118.57 76
Rev-Margin DCF $91.44 $136.81 $187.27 74
All 26 models by family
DCF Models
FCF DCF $104.30 $150.36 $215.33 38
Owner Earnings $90.85 $130.67 $186.83 31
5Y Revenue Exit $91.44 $135.90 $191.10 39
5Y EBITDA Exit $112.03 $173.37 $243.01 41
5Y P/E Exit $112.11 $173.52 $236.03 38
10Y Revenue Exit $93.04 $133.57 $184.93 36
10Y EBITDA Exit $108.10 $158.63 $222.69 37
10Y P/E Exit $108.15 $158.73 $217.61 35
Earnings-Based
Graham-Dodd $52.25 $140.94 $184.57 54
Lynch FV $27.59 $39.42 $51.24 50
PEG = 1.0 $27.59 $39.42 $51.24 46
EPV $65.33 $74.86 $83.07 59
Dividend Discount
Gordon GGM $21.76 $43.36 $65.66 70
DDM Multi-Stage $21.76 $33.33 $45.14 61
Multiples
P/E Multiple $126.78 $169.04 $211.30 63
P/S Multiple $97.97 $130.62 $163.28 58
P/B Multiple $97.97 $130.62 $163.28 55
EV/EBIT $122.12 $161.15 $200.18 53
EV/EBITDA $131.65 $173.86 $216.07 54
EV/Revenue $88.60 $124.41 $160.23 43
Asset-Based
NCAV (Graham) $34.21 $45.84 $68.42 50
Growth DCF
Growth DCF $106.31 $147.86 $203.42 80
Rev-Margin DCF $91.44 $136.81 $187.27 74
Economic Profit
Residual Income $61.18 $69.38 $118.57 76
ROIC Compounder $65.33 $77.64 $93.24 72
Growth Earnings
Growth-Adj P/E $99.60 $142.29 $184.98 68

Widest divergence: DCF Models ($150.36) versus Dividend Discount ($33.33). Highest evidence: Growth DCF (80).

Key figures & financial health

Revenue (TTM) $1.5B
Revenue growth (YoY) +2.2%
Net margin 8.1%
Return on equity 12.0%
Free cash flow $149M FY2025
P/E ratio 26.7
More key figures
Operating margin 8.5%
EPS (TTM) $7.87
Dividend yield 1.2%
EPS growth (YoY) +9.7%
Net cash $23.9M FY2025

Figures from reported company fundamentals · as of Jul 14, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 72/100

Of which business quality 73 · Market factors (momentum, volatility) 89

Profitability 63
Margins and returns on capital today
Quality Growth 77
Are margins and returns improving?
Cashflow 61
Earnings quality: real cash, not paper profit
Fin. Strength 85
Balance sheet, leverage, solvency risk
Investment 77
Disciplined investing over empire-building
Low Volatility 74
Calm price path (market factor)
Momentum 94
Price trend over the last 3–12 months (market factor)
52W Momentum 98
Distance to the 52-week high (market factor)
Net Issuance 78
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

About the company

National HealthCare Corporation engages in the operation of services to skilled nursing facilities, assisted and independent living facilities, homecare and hospice agencies, and health hospitals. It operates through two segments: Inpatient and Homecare and Hospice Services.

Full company description

National HealthCare Corporation engages in the operation of services to skilled nursing facilities, assisted and independent living facilities, homecare and hospice agencies, and health hospitals. It operates through two segments: Inpatient and Homecare and Hospice Services. The company's skilled nursing facilities offer licensed therapy services, nutrition services, social services, activities, and housekeeping and laundry services, as well as medical services prescribed by physicians; and rehabilitative services, such as physical, speech, respiratory, and occupational therapy for patients recovering from strokes, heart attacks, orthopedic conditions, neurological illnesses, or other illnesses, injuries, or disabilities. It provides medical specialty units comprise memory care units and sub-acute nursing units that provide specialized care and programs for persons with Alzheimer's or related disorders; and assisted living facilities offer personal care services and assistance with general activities of daily living, such as dressing, bathing, meal preparation, and medication management. Its independent living facilities offers specially designed residential units for the active and ambulatory elderly and provide various ancillary services for residents, including restaurants, activity rooms and social areas; and behavioral health services to both adults and geriatric patients with psychiatric, emotional, and addictive disorders. In addition, the company homecare agencies assist those who wish to stay at home or in assisted living residences but still require some degree of medical care or assistance with daily activities; hospice agencies that provides hospice and palliative care; and operates pharmacies, as well as managed care insurance solutions. Further, the company offers management, accounting, and financial services; and leases its properties to third party operators. The company was founded in 1971 and is based in Murfreesboro, Tennessee.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

National HealthCare Corporation reported revenue of $1.5B in FY2025 versus $1.0B in FY2021, a compound +10.6%/yr. Reported net income was $120M in FY2025, compounding −3.5%/yr from FY2021.

Growth Quality 83/100
Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Latest Revenue (FY 2025)
$1.5B
Latest YoY
+16.4%
Avg. growth/yr (3Y)
+12.0%
Avg. growth/yr (5Y)
+9.0%
Avg. growth/yr (34Y)
+6.4%
Revenue +10.6%/yr
FY21 $1.0B
FY22 $1.1B
FY23 $1.1B
FY24 $1.3B
FY25 $1.5B
Net income −3.5%/yr
FY21 $139M
FY22 $22.4M
FY23 $66.8M
FY24 $102M
FY25 $120M

NHC screens 27% overvalued. Compare with HCA Healthcare, Inc →

Share or link this analysis
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "National HealthCare Corporation Fair Value". https://www.fairvalue-calculator.com/stock/NHC

Earlier news

External third-party headlines (Yahoo Finance, Reuters and others), not an editorial selection.

Peer Group

Medical Care Facilities · 262 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 72 · Top 25%
Fair Value upside −27% · Below median
Return on equity (TTM) 12% · Above median
Return on assets 5% · Above median
Net margin (TTM) 8% · Above median
Operating margin (TTM) 8% · Below median
Revenue growth 2% · Below median
Dividend yield (TTM) 1.2% · Below median
Debt / equity 0.03× · Lower than median

Valuation Multiples vs Medical Care Facilities median · lower = cheaper

P/E (TTM) 26.7× · Pricier than median
P/B 3.07× · Pricier than 75% of peers
P/S (TTM) 2.15× · Pricier than 75% of peers
P/FCF 22.1× · Pricier than 75% of peers
EV/EBITDA 18.3× · Pricier than 75% of peers
PEG 0.82× · Cheaper than 75% of peers

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUE 0 · sector 22
FUTURE 11 · sector 24
PAST 48 · sector 30
HEALTH 99 · sector 90
DIVIDEND 24 · sector 38

VALUE 0: the price sits above our fair-value range.

Insider activity: 40/100

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Medical Care Facilities stocks, each showing price versus our Fair Value estimate (as of Jul 14, 2026).

Stock Price Fair Value vs Fair Value
HCA Healthcare, Inc HCA $378.85 $554.93 +46%
Fresenius SE FRE €41.73 €32.15 -23%
Dr. Sulaiman Al Habib Medical Services Group 4013 235.00 SAR 112.37 SAR -52%
IHH Healthcare Berhad, an investment holding company, Q0F 2.58 SGD 1.44 SGD -44%
Tenet Healthcare Corporation THC $194.91 $338.05 +73%
Rede D'Or São Luiz S.A RDOR3 R$36.01 R$47.31 +31%
DaVita Inc DVA $231.61 $255.97 +11%
Apollo Hospitals Enterprise Limited APOLLOHOSP ₹8,955 ₹2,955 -67%
Fresenius Medical Care AG FMS $24.68 $45.60 +85%
Aier Eye Hospital Group 300015 ¥8.68 ¥7.67 -12%

Compare National HealthCare Corporation with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Frequently asked questions

Is National HealthCare Corporation (NHC) overvalued or undervalued?
As of Jul 14, 2026, our model estimates a fair value of $157.66 versus a price of $215.54, about −27% (overvalued).
What is the fair value of NHC?
Our model-based fair value for National HealthCare Corporation is $157.66 (as of Jul 14, 2026), built from audited fundamentals. The current price is $215.54.
What is the quality score of NHC?
National HealthCare Corporation has a Quality Score of 72/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the revenue of National HealthCare Corporation (NHC)?
National HealthCare Corporation reported trailing-twelve-month revenue of about $1.5B (latest available figure, as of Jul 14, 2026).
What is the net profit margin of NHC?
The net profit margin of National HealthCare Corporation is about 8.1%, meaning it keeps roughly 8.1% of revenue as net income. Based on the latest reported figures.
Does National HealthCare Corporation pay a dividend?
National HealthCare Corporation currently shows a dividend yield of about 1.37% relative to its recent price (as of Jul 14, 2026).

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Track National HealthCare Corporation and try Pro for 14 days

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.